Comparison of Ambulatory and Functional Improvement by Morning Walk

Comparison of Clinical Efficacy and Safety for Ambulatory and Functional Improvement in Patients After Total Knee Arthroplasty With Morning Walk

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03183856

Enrollment

Registered

2017-06-12

Start date

2017-09-15

Completion date

2018-05-25

Last updated

2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Knee, Robotics

Brief summary

The aim of this study is to determine the clinical efficacy and feasability of gait rehabilitation robot through approving functional improvement by an end-effector typed gait robot in patients underwent total knee arthroplasty.

Detailed description

pre-interventional evaluation; within 1 day of initiation of the intervention; 5 days after initiation of the intervention; 10 days after intervention after initiation of the intervention; 42 days after intervention start

Interventions

DEVICEMorning walk

a end-effector typed gait robot with a saddle

OTHERno Morning walk

ambulation voluntary or with a help of walker

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients underwent Unilateral or both Total Knee Arthroplasty

Exclusion criteria

* brain disease, spinal cord injury, peripheral neuropathy, myopathy * Inability to ambulate fully due to muscukoskeletal disorders * MMSE\<23 * history of arthroplasty surgery on either of legs * Cardiac pacemaker * Refusal of participation

Design outcomes

Primary

Measure	Time frame	Description
Change of WOMAC index	1 day before the initiation of intervention), 5 day, 10 day, and 31 days after the initiation of intervention	Western Ontario and McMaster Universities Osteoarthritis Index

Secondary

Measure	Time frame	Description
Change of VAS	1 day before the initiation of intervention), 5 day, 10 day, and 31 days after the initiation of intervention	visual analogue scale

Other

Measure	Time frame	Description
Change of ROM	1 day before the initiation of intervention), 5 day, 10 day, and 31 days after the initiation of intervention	range of motion of the operated knee
Change of drug consumption	5 day, and 10 day after the initiation of intervention	weekly amount of tridol consumption
Change of 6 minute walk test	1 day before the initiation of intervention), 5 day, 10 day, and 31 days after the initiation of intervention	6 minute walk test

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026